Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on ...

The business remains strong, contracts keep flowing, and yet the share price is far lower than it was a year ago. The post ...

Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing ...

Analysts think these top stocks are great options for Aussie investors. Let's see what makes them stand out. The post Top ...

Find insight on Roche Holdings, U.S. healthcare stocks and more in the latest Market Talks covering the health care sector.

Here's why brokers believe that now could be the time to buy these shares. The post Leading brokers name 3 ASX shares to buy ...

Some of Australia's leading tech names have seen their share prices halved in recent months. Are these three ASX tech leaders now a buy?

Leaders from medical marketing shops like AbelsonTaylor Group, Merge and Citrus Health weigh in on Omnicom’s impact on the Chicago ad scene.

An AI scribe from X-on Health will be able to transcribe notes from GP telephone conversations, as well as in person appointments.

Cardiology’s shift to the outpatient setting is accelerating, but leaders say anesthesia capacity could become a limiting factor as more complex procedures move beyond the hospital. In its 2026 final ...

Asia-Pacific markets advanced on Tuesday, tracking gains on Wall Street, with South Korea leading regional outperformance ...